SCHEMBL21396905

SCHEMBL21396905

COc1ccc(N2CCC(CN)CC2)cn1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 4/20 0.56
CHRNA4 P43681 4/20 0.56
CHRNB4 P30926 2/20 0.56
CHRNA3 P32297 2/20 0.56
OGA O60502 1/20 0.44
OXTR P30559 6/20 0.44
AVPR1A P37288 6/20 0.44
HRH4 Q9H3N8 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
LCAT P04180 1/20 0.41
F10 P00742 1/20 0.41
NTRK1 P04629 2/20 0.41
CSF1R P07333 2/20 0.41
NTRK2 Q16620 2/20 0.41
AKT2 P31751 2/20 0.41
GSK3B P49841 1/20 0.41
DPP4 P27487 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4393507 0.85 CHRNB2 (0.56) CHRNB2CHRNA4CHRNB4CHRNA3OGA
SCHEMBL4391755 0.85 CHRNB2 (0.58) CHRNB2CHRNA4CHRNB4CHRNA3OGA
SCHEMBL21397330 0.85 CHRNB2 (0.59) CHRNB2CHRNA4CHRNB4CHRNA3OGA
SCHEMBL24632524 0.81 AKT2 (0.44) CHRNB2CHRNA4HRH3AKT2GSK3B
SCHEMBL31625156 0.81 AKT2 (0.44) CHRNB2CHRNA4HRH3AKT2GSK3B
SCHEMBL785009 0.79 CHRNB2 (0.56) CHRNB2CHRNA4CHRNB4CHRNA3OGA
Hydrochloric Acid SCHEMBL21384628 0.79 CHRNB2 (0.53) CHRNB2CHRNA4CHRNB4CHRNA3OGA
SCHEMBL26094391 0.79 CHRNB2 (0.53) CHRNB2CHRNA4CHRNB4CHRNA3LCAT
Hydrochloric Acid SCHEMBL30574425 0.79 CHRNB2 (0.53) CHRNB2CHRNA4CHRNB4CHRNA3OGA
SCHEMBL8123113 0.78 HRH4 (0.56) HRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019179362-A1 AMIDINE AND GUANIDINE DERIVATIVES, PREPARATION METHOD THEREFOR AND MEDICAL USES THEREOF 四川科伦博泰生物医药股份有限公司 2019-09-26 WO disclosed